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341Assessment of Paravalvular
Regurgitation Following TAVR
A Proposal of Unifying Grading SchemeABSTRACTParavalvular regurgitation (PVR) is a frequent complication of transcatheter aortic valve replacement that has
been shown to be associated with increased mortality. The objective of this article is to review the most
up-to-date information about the assessment and management of PVR and to propose a new more comprehensive
and unifying scheme for grading PVR severity. A multimodality, multiparametric, integrative approach including
Doppler echocardiography, cineangiography, hemodynamic assessment, and/or cardiac magnetic resonance is
essential to accurately assess the severity of PVR and the underlying etiology. Corrective procedures such as
balloon post-dilation, valve-in-valve, or leak closure may be considered, depending on the severity, location, and
etiology of PVR. (J Am Coll Cardiol Img 2015;8:340–60) © 2015 by the American College of Cardiology
Foundation.T ranscatheter aortic valve replacement (TAVR)is a rapidly expanding alternative to surgicalreplacement for patients with high operative
risk. Paravalvular regurgitation (PVR) is, however,
an important complication of TAVR that has been
shown to be associated with increased mortality for
both the balloon-expandable and the self-expanding
transcatheter heart valves (THV) (1,2). Thus, the accu-
rate measurement of this complication becomes
an important means for determining the effec-
tiveness of various corrective interventions (such
as post-dilation or valve-in-valve) as well as the effec-
tiveness of various valve iterations or designs. The
objective of this article is to review the most up-
to-date information about the assessment and man-
agement of PVR and to propose a new unifying
scheme for grading PVR severity, which would bring
clarity and uniformity to grading of PVR.
INCIDENCE AND CLINICAL IMPACT OF PVR
INCIDENCE OF PVR. The incidence of moderate or
severe PVR following TAVR varies from 0% to 24%
and that of mild PVR from 7% to 70%, depending
on the studies (Online Figure 1, Online Appendix)
(1–4). These important inconsistencies in reported
incidences of PVR are multifactorial and may be due
to differences in: 1) the baseline risk proﬁle of the
populations; 2) the type of THV and approach used
for TAVR; 3) the method of assessment of PVR (cin-
eangiography versus hemodynamics versus cardiac
magnetic resonance [CMR] versus echocardiography)
(5); 4) the parameters and criteria relied upon to
grade PVR; 5) the type of grading (i.e., 3- vs. 4-class)scheme used to classify PVR severity; and 6) the
standardization of the assessment of PVR (i.e., site
vs. core lab reported) (Table 1).
CLINICAL IMPACT OF PVR. In a meta-analysis (4),
moderate/severe PVR was associated with a 3-fold
increase in 30-day mortality and a 2.3-fold increase
in 1-year mortality following TAVR. The studies on
the impact of mild PVR on outcomes have yielded
conﬂicting results (1,4,6–8). In the PARTNER-IA
(Placement of AoRTic TraNscathetER Valves) study
randomized TAVR arm, the impact of mild PVR on
survival was as important as that of moderate/severe
PVR (w2-fold increase in the risk of mortality) (1). In
a recent analysis of the PARTNER-IA randomized
and nonrandomized continued access cohorts, mild
PVR was independently associated with a 1.37-fold
increase in all-cause mortality after adjustment
for other comorbidities (6). However, in several
large registries, moderate or greater PVR, but not
mild PVR, was shown to have a signiﬁcant impact on
survival (2,7,8). Several factors may explain the
intriguing association between mild PVR and mor-
tality: 1) the pitfalls in the grading of PVR and the
possibility that it may have been underestimated in
a substantial number of patients (or that moderate
PVR may have been overestimated); and 2) the
worse baseline risk proﬁle of patients with mild
PVR versus those with none or trace PVR (6,9).
Furthermore, even a mild PVR may have a detri-
mental impact in patients with small, thick, and
noncompliant ventricles, such as is often the case in
the population with severe aortic stenosis (AS) un-
dergoing TAVR (7,10).
FIGURE 1 AR Index for the A
The aortic regurgitation (AR) ind
diastolic transvalvular pressure
(PVR) (A), the AR index is 16.7, w
pressure in the aorta; LVEDP ¼
ABBR EV I A T I ON S
AND ACRONYMS
AR = aortic regurgitation
AS = aortic stenosis
ASE = American Society of
Echocardiography
CMR = cardiac magnetic
resonance
LV = left ventricle/ventricular
LVOT = left ventricular outﬂow
tract
PVR = paravalvular
regurgitation
RV = right ventricle/ventricular
TAVR = transcatheter aortic
valve replacement
TEE = transesophageal
echocardiography
THV = transcatheter heart
valve
TTE = transthoracic
echocardiography
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342PROPOSAL OF A NEW UNIFYING
SCHEME FOR GRADING PVR BY
ECHOCARDIOGRAPHY
Several studies have used the 3-class grading
scheme (mild, moderate, severe) proposed in
the most recent guidelines (11–14) to report
the severity of PVR, whereas other studies
have employed the 4-class scheme (Grades 1,
2, 3, 4) often used clinically to grade native or
prosthetic aortic regurgitation (AR) (Table 1).
Among the studies that have applied this
4-class scheme, there is often ambiguity or
even frank differences in Grades 2 and 3; the
Grade 2 class is considered as an equivalent
to mild AR in some studies, whereas it is
considered as moderate in others, and Grade
3 is considered moderate in some studies and
moderate to severe in others.
To better understand the possible
contribution to differences in grading
attributable to the broad categories of mild,moderate, and severe, and to align the grading
scheme with the commonly used clinical scheme
that uses “between-grade” options, we propose us-
ing an expanded grading scheme. When the reader
is only offered a grading scheme with 3 broad
classes, he or she would have a tendency to select
the class in the middle (i.e., the moderate class)
if there is a hesitation between 2 classes (mild vs.ssessment of PVR Severity
ex can be used for quantitating AR severity following transcathe
gradient to the systolic blood pressure measured by left heart cat
hereas in the patient with trace PVR (B), the index is 30.8. Adapt
left-ventricular end-diastolic pressure; SBP ¼ systolic blood presmoderate or moderate vs. severe). We believe that
the 5-class scheme will provide more ﬂexibility for
the grading of PVR and will therefore have the
potential to improve the overall accuracy and
reproducibility of PVR grading by echocardiography
(15).
This proposed grading scheme follows clinical
practice to divide: 1) mild PVR into 2 separate
grades: mild and mild-to-moderate; and 2) moderate
PVR into moderate and moderate-to-severe. This
results in a 5-class grading scheme. The intent is
that the 5 classes of grading would then be easily
collapsed and reported with the 3-class scheme
recommended by the American Society of Echocar-
diography (ASE)–European Association of Cardiovas-
cular Imaging guidelines (11,14). It is recognized that
more grades would initially produce greater vari-
ability but if the additional grades are used only as
an interim step and then collapsed to the grades
used in the guidelines, it may derive the beneﬁts
from clinical application and ultimately reduce vari-
ability. Furthermore, it also allows uniﬁcation and
clariﬁcation of several different grading scales. Table 1
presents the proposed qualitative, semiquantitative,
and quantitative parameters of each class of this new
grading scheme, as well as the correspondence with
other existing schemes (3-class and 4-class). The
echocardiographic parameters and criteria used to
support this 5-class grading scheme are presented in
the next section. Obviously, this new scheme willter heart valve (THV) deployment; it is calculated as the ratio of the
heterization. In the patient with moderate paravalvular regurgitation
ed with permission from Sinning et al. (16). DBP ¼ end-diastolic blood
sure in the aorta.
TABLE 1 Scheme, Modalities, Parameters, and Criteria for Grading the Severity of PVR
3-Class Grading Scheme Trace Mild Mild Moderate Moderate Severe
4-Class Grading Scheme 1 1 2 2 3 4
Unifying 5-Class Grading Scheme Trace Mild Mild-to-Moderate Moderate Moderate-to-Severe Severe
Cineangiography Grade 1 Grade 1 Grade 1 Grade 2 Grade 3 Grade 4
Invasive hemodynamics
Aortic regurgitation index* >25 >25 >25 10–25 10–25 <10
Doppler echocardiography
Structural parameters
C Valve stent Usually normal Usually normal Normal/abnormal† Normal/abnormal† Usually abnormal† Usually abnormal†
B LV size‡ Normal Normal Normal Normal/mildly dilated Mildly/moderately dilated Moderately/severely dilated
Doppler parameters (qualitative or semiquantitative)
C Jet features§
Extensive/wide jet origin Absent Absent Absent Present Present Present
Multiple jets Possible Possible Often present Often present Usually present Usually present
Jet path visible along the stent Absent Absent Possible Often present Usually present Present
Proximal ﬂow convergence visible Absent Absent Absent Possible Often present Often present
B Vena contracta width (mm): color Dopplerk <2 <2 2–4 4–5 5–6 >6
B Vena contracta area (mm2): 2D/3D color Doppler¶ <5 5–10 10–20 20–30 30–40 >40
C Jet width at its origin (%LVOT diameter):
color Dopplerk
Narrow (<5) Narrow (5–15) Intermediate (15–30) Intermediate (30–45) Large (45–60) Large (>60)
B Jet density: CW Doppler Incomplete or faint Incomplete or faint Variable Dense Dense Dense
B Jet deceleration rate (PHT, ms): CW Doppler*‡ Slow (>500) Slow (>500) Slow (>500) Variable (200–500) Variable (200–500) Steep (<200)
B Diastolic ﬂow reversal in the descending aorta:
PW Doppler*‡
Absent Absent or brief early diastolic Intermediate Intermediate Holodiastolic
(end-diast. vel. >20 cm/s)
Holodiastolic
(end-diast. vel. >25 cm/s)
C Circumferential extent of PVR (%): color Dopplerk <10 <10 10–20 20–30 >30 >30
Doppler parameters (quantitative)
B Regurgitant volume (ml/beat)# <15 <15 15–30 30–45 45–60 >60
B Regurgitant fraction (%) <15 <15 15–30 30–40 40–50 >50
B Effective regurgitant oriﬁce area (mm2)** <5 <5 5–10 10–20 20–30 >30
Cardiac magnetic resonance imaging
Regurgitant fraction (%)†† <10
<15
<10
<15
10–20
15–25
20–30
15–25
20–30
25–50
>30
>50
C Parameters that are most frequently applicable and used to grade PVR severity by echocardiography.B Parameters that are less often applicable due to pitfalls in the feasibility/accuracy of the measurements and/or to the interaction with other factors. Online
Videos 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, and 36 provide Doppler color images (parasternal short- and long-axis, apical 5- and 3-chamber views) of representative cases for each class (except none and severe PVR) of the
unifying 5-class grading scheme proposed in this table. *These parameters are inﬂuenced by LV and aortic compliance. In particular, low transvalvular end-diastolic aorta to LV pressure gradient that is due to concomitant moderate/severe LV diastolic dysfunction may
lead to false-positive results. The high dependency of aortic ﬂow reversal on aortic compliance considerably limits the utility of this parameter in the elderly population undergoing TAVR. These parameters are also inﬂuenced by chronotropy. †Abnormalities of stent
position (too low or too high), deployment, and/or circularity. ‡Applies to chronic PVR but is less reliable for periprocedural or early post-procedural assessment. §See Figure 9 for illustrative images. kThese parameters are generally assessed visually. ¶The vena
contracta area is measured by planimetry of the vena contracta of the jet(s) on 2D or 3D color Doppler images in the short-axis view (Figure 8). #Regurgitant volume is calculated as the difference of stroke volume measured in the LV outﬂow tract minus the stroke
volume measured in the right ventricular outﬂow tract (see Figure 10). **The effective regurgitant oriﬁce area is calculated by dividing the regurgitant volume by the time-velocity integral of the AR ﬂow by CW Doppler. ††There are important variability in the cutpoint
values of regurgitant fraction and volume reported in the published studies to grade AR by cardiac magnetic resonance imaging.
2D¼ 2-dimensional; 3D¼ 3-dimensional; AR¼ aortic regurgitation; CW¼ continuous wave; end diast. vel.¼ end-diastolic velocity; LV¼ left ventricular; LVOT¼ left ventricular outﬂow tract; PHT¼ pressure half-time; PVR¼ paravalvular regurgitation; PW¼ pulsed
wave; RV ¼ right ventricular; TAVR ¼ transcatheter aortic valve replacement.
J
A
C
C
:
C
A
R
D
IO
V
A
S
C
U
L
A
R
IM
A
G
IN
G
,
V
O
L
.
8
,
N
O
.
3
,
2
0
1
5
Pibarot
et
al.
M
A
R
C
H
2
0
1
5
:3
4
0
–
6
0
A
ssessm
ent
of
Paravalvular
R
egurgitation
343
FIGURE 2 Transes
Multiple views shoul
simultaneous 2-dime
sinus of Valsalva. B is
The blue arrow indic
views, jet length and
moderate-to-severe
Pibarot et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 3 , 2 0 1 5
Assessment of Paravalvular Regurgitation M A R C H 2 0 1 5 : 3 4 0 – 6 0
344have to be validated with PVR severity data deter-
mined by other modalities (e.g., CMR) and, more
importantly, with outcome data.
IDENTIFICATION AND
QUANTITATION OF PVR
Several modalities may be used to identify and
quantitate PVR, and each of these modalities has
inherent limitations and technical pitfalls. Echocar-
diography remains the most frequently used modality
to detect, grade, and follow PVR. During the proce-
dure, transesophageal echocardiography (TEE), cin-
eangiography, and/or invasive hemodynamics are
utilized to assess PVR, whereas transthoracicophageal Color Doppler Echocardiographic Views for the Assessment of P
d be used to assess paravalvular regurgitation (PVR) by transesophageal ech
nsional (2D) and color Doppler imaging at the mid-transcatheter heart valve
at the level of the leaﬂets with color jet between the yellow arrows likely rep
ates trivial central aortic regurgitation (AR). C is from the deep transgastric vie
area may exaggerate the severity of the PVR. D to I present representative
(H), and severe (I) PVR.echocardiography (TTE) is generally used for the
assessment and follow-up of PVR after the procedure.
TTE is also used in place of TEE for periprocedural
assessment when TAVR is performed under conscious
sedation only.
CINEANGIOGRAPHY. Semiquantitative assessment of
AR can be obtained during the procedure by assessing
the relative density of contrast media in the left
ventricle by cineangiography (16,17). AR severity is
classiﬁed according to the visually estimated density
of opaciﬁcation of the left ventricle (LV) into 4 grades
(13,16). However, cineangiography is highly subjec-
tive and dependent on observer’s experience as well
as the numerous technical factors (i.e., the intensityVR
ocardiography (TEE). A is a mid-esophageal short-axis view with
(THV) level. A small jet of color (yellow arrow) represents ﬂow in the
resenting turbulent ﬂow between the native calciﬁed cusps and THV.
w, and multiple jets of PVR are seen (yellow arrows). Note: from these
cases of none (D), mild (E), mild-to-moderate (F), moderate (G),
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345of ﬂuoroscopy, the use of single or biplane imaging,
the volume of the contrast medium injected, the
type and position of the catheter tip), which result in
signiﬁcant variability in grading. In addition, this
method has not been validated for the post-TAVR
population, where atypical, multiple, localized jets
may inﬂuence the density of contrast seen in the
ventricle. Recently, quantitative densitometry has
been proposed as a more reproducible measure of AR
following TAVR by comparing the density of the
contrast in the aorta with that in the ventricle (18).
Many patients undergoing TAVR have renal insufﬁ-
ciency, and therefore, it is prudent to minimize the
contrast load; this is another reason why cine-
angiography may not be the modality of choice in this
setting.
HEMODYNAMIC ASSESSMENT. Invasive hemodynamic
measurements may provide additional informationFIGURE 3 Location of the PVR Jets in the Different Transthoracic E
Schematic representations of transthoracic echocardiographic (TTE) view
apical 5-chamber view (C); apical 3-chamber view (D) (see Figure 4 for
described according to the face of a clock applied on the short-axis view
reference (A). The jets with anterior location (10 to 2 o’clock) are represen
in red, and the jets with lateral or medial locations (8 to 10 and 2 to 4 o
permission from Gonçalves et al. (23).on the severity of AR during the procedure. Sinning
et al. (16) proposed calculating the AR index to assess
the severity of PVR during TAVR: AR index ¼ [(DBP 
LVEDP)/SBP]  100, where DBP and SBP are diastolic
and systolic blood pressures, and LVEDP is the LV
end-diastolic pressure (Figure 1). An index of <25%
was predictive of increased 1-year mortality in both
patients with none/mild PVR and those with moder-
ate/severe PVR, suggesting that the severity of
regurgitation may not be the only determinant of the
AR index. A false-positive AR index can be seen with
abnormal ventricular or aortic compliance. Nonspe-
ciﬁc elevation of the LV end-diastolic pressure in the
setting of severe LV diastolic dysfunction, as well as
increased aortic stiffness resulting in diastolic reversal
of ﬂow, may lead to a low end-diastolic transvalvular
gradient in the absence of signiﬁcant AR. Similar to
angiographic grading, there is a signiﬁcant overlapchocardiographic Views
s: parasternal short-axis view (A); parasternal long-axis view (B);
representative TTE images and videos). The location of the jets are
with the insertion of the tricuspid valve leaﬂet set as the 9 o’clock
ted in blue in all views; the jets with posterior location (4 to 8 o’clock)
’clock) are in orange. PVR ¼ paravalvular regurgitation. Adapted with
FIGURE 4 Multiview, Multiplane TTE Imaging for the Assessment of PVR
Parasternal short-axis view (A) (Online Video 1); parasternal long-axis view (B) (Online Video 2); apical 5-chamber view (C) (Online Video 3);
apical 3-chamber view (D) (Online Video 4). The yellow arrow indicates a small anterior jet, and the white arrow a larger posterior jet.
The posterior jet is not well visualized and largely underestimated in the parasternal views (A and B). E, F, G, and H (Online Videos 5, 6, 7,
and 8) underline the importance of rotational sweeps in the apical 5- and 3-chamber views to obtain multiplane imaging and
therefore optimize the visualization and assessment of PVR jet(s). The schematic representation in the left panels shows the location of the
image plane in the short-axis view. I shows a color Doppler TTE image and a schematic representation of a case with a central regurgitation
(thin white arrow) and a posterior PVR (thin yellow arrow) (Online Video 9). The posterior jet merges with the systolic mitral ﬂow (large
white arrow), making difﬁcult the visualization of the origin of this jet and the grading of PVR severity. Abbreviations as in Figure 3.
Continued on the next page
Pibarot et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 3 , 2 0 1 5
Assessment of Paravalvular Regurgitation M A R C H 2 0 1 5 : 3 4 0 – 6 0
346between grades, and the AR index does not differen-
tiate between central or paravalvular regurgitation.
Another pitfall of the AR index is that it is dependent
on heart rate. In many respects, it is analogous
to the continuous-wave Doppler pressure half-time
method (see the following text) and carries similar
limitations. Hence, intraprocedural decision making
using this index should integrate this index with
other imaging modalities such as echocardiography.
ECHOCARDIOGRAPHY. PVR jets are often multiple,
eccentric, and of irregular shape (Figures 2 to 6,Online Videos 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12)
(9,11). Furthermore, they are conﬁned along the left
ventricular outﬂow tract (LVOT) wall, and they may
be masked partially or totally as a result of acoustic
shadowing from the calciﬁcations of the native aortic
annulus or from the THV stent. These features render
the echocardiographic imaging, detection, and
quantiﬁcation of PVR particularly challenging.
Several parameters and criteria have been proposed
in the recent ASE–European Association of Cardio-
vascular Imaging and Valve Academic Research
FIGURE 4 Continued
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347Consortium 2 guidelines (11,13,14) to assess PVR by
echocardiography (Table 1). However, because of the
particular nature of PVR jet(s), several of the semi-
quantitative or quantitative parameters that are
generally used to grade native AR (12) are difﬁcult or
impossible to apply to the context of PVR (11,13,14). In
the following subsections, we present the parameters
proposed in the guidelines, as well as other additional
parameters that can be used to support the classiﬁ-
cation of PVR severity according to the 3-class, 4-
class, and proposed 5-class grading schemes (Table 1).
Structural parameters. THV stent position and
shape. Although the presence of abnormalities of
THV stent position or shape provides supportive
ﬁndings to identify and grade PVR, these ﬁndings
lack sensitivity and speciﬁcity. The parasternallong- and short-axis views are generally the best
views to assess THV stent position and shape. PVR
that is moderate or greater is often associated
with: 1) inappropriate low (or high) stent position;
2) noncircular/irregular stent shape; and 3) clearly
visible free space between stent and native aortic
annulus. Real-time 3-dimensional (3D) echocardiog-
raphy may help to identify and assess abnormalities
of THV stent shape and position.
LV size and function. In the periprocedural and early
post-procedural (<3 months) period, a signiﬁcant
increase in LV diameter and/or deterioration in LV
ejection fraction compared with pre-procedural
echocardiography should raise the level of concern
with regard to the presence of signiﬁcant PVR.
However, these ﬁndings have a relatively low
FIGURE 5 Circumferential Extent of the PVR According to the Jet Location and Plane of Interrogation
(A) Shows a longitudinal unfold view of the left ventricular outﬂow tract (LVOT), transcatheter heart valve (THV), native valve, and aortic root.
(B, C, D, E) Show the short-axis cross sections at different levels: LVOT (B) and lower (C), mid (D), and upper (E) portions of the THV.
The extent of the paravalvular circumference occupied by the regurgitant jet(s) can be used to assess the severity of the regurgitation (C, D).
(A, C, D) The paravalvular regurgitation (PVR) most frequently occurs at the location of the native valve commissures (i.e., between right and
left coronary cusps: 1 to 2 o’clock on the short-axis view; left and non-coronary cusps: 5 to 6 o’clock; and non- and right coronary cusps: 10 to 11
o’clock). Given that the extension of these jets at the commissures is determined by the size of the native intervalvular triangle, they tend to
splay widely as they ﬂow toward the lower portion of the THV stent and LVOT (black arrows). The circumferential extent of these jets may thus
vary markedly depending on the plane of interrogation used for the short-axis view. The jets arising from malapposition of the THV stent, most
frequently due to bulky calciﬁcation of the native cusp, are generally more restricted with less splaying in the LVOT (white arrow). (F, G, H) In
this example, the size of the PVR jet is dependent on the level of imaging. Panel F is a short-axis image at the level of the aortic root near the
left main coronary artery (red arrow). Panel G is at the level of the THV leaﬂets (blue arrow) and shows a small PVR jet (yellow arrow). H is
slightly lower, near the ventricular edge of the THV stent and the aortic regurgitant jet is much larger. (I and J) In this example, the size of the
PVR jet is also dependent on the level of imaging. I is a simultaneous multiplane image with the long axis showing the level of the orthogonal
short-axis view (blue arrow). The short-axis view has 2 turbulent color Doppler jets associated with the stent frame. In J, the orthogonal view is
within the LVOT and no PVR is seen. A, B, C, D, and E are adapted with permission from Tuzcu et al. (20).
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348speciﬁcity and, more importantly, a low sensitivity in
the acute post-TAVR phase. Indeed, immediately
after procedure, a large proportion of patients with
moderate or greater PVR have no signiﬁcant LV
dilation. The consideration of the LV cavity size
becomes more useful in the context of chronic THV
regurgitation (Table 1). In the late (>3 to 6 months)
post-TAVR phase, the presence of moderate or
greater PVR is expected to be associated with
signiﬁcant LV dilation during follow-up, and its
absence should, in most situations, preclude the
diagnosis of signiﬁcant regurgitation, whereas its
presence should increase the level of suspicion.
Color Doppler parameters. For both TEE and TTE
evaluation of PVR, it is essential to obtain colorDoppler images in multiple views and multiple
planes (Figures 2 to 6, Online Videos 1, 2, 3, 4, 5, 6, 7,
8, 9, 10, 11, and 12) to ensure complete visualization of
the paravalvular region and proper detection and
assessment of all PVR jets.
With TEE, the PVR jets are best visualized in the
mid-esophageal long-axis view of the THV, mid-
esophageal short-axis view just below the level of
the stent, and transgastric views (Figure 2). Multiple
short-axis levels of the THV (from the level of the
leaﬂets to below the stent frame) should be evalu-
ated. Deep transgastric views of the THV allow for a
multiangle rotation to assess the entire circumference
of the valve (Figure 2). Although jet length and width
should not be used to assess severity, the number of
Continued on the next page
FIGURE 5 Continued
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349jets and the size of the jet origin may be helpful in
determining PVR severity.
With TTE, the 4 main views that should be ac-
quired are the parasternal short-axis, parasternal
long-axis, apical 5-chamber, and apical 3-chamber
views (Figures 3 and 4, Online Videos 1, 2, 3, and 4).
For the short-axis view, it is very important to do an
aorta-to-LVOT sweep and acquire images at several
levels of the valve stent (Figure 5). A lateral-to-medial
sweep is also useful in the parasternal long-axis view.
For the apical views, it is important to perform
translational (lateral to medial, anterior to posterior)
and rotational (5-chamber to 4-chamber to 3-
chamber) sweeps and acquire off-axis and interme-
diary (e.g., between 5- and 4-chamber) views (Figures
4E, 4F, 4G, and 4H, Online Videos 5, 6, 7, and 8).
Detection and localization of the PVR jets: Because
of the shadowing caused by the native aortic valve
calciﬁcations and the THV stent, the PVR jets located
posteriorly are often totally or partially masked in the
parasternal long-axis or short-axis TTE views
(Figures 3, 4A, 4B, 4C, and 4D, Online Videos 1, 2, 3,
and 4). Apical views should thus be carefully exam-
ined to properly detect and quantitate these posterior
jets. Conversely, with TEE, the anterior jets may be
underdetected or underestimated in some views as aresult of this shadowing phenomenon. The PVR jets
located on the lateral or medial aspects of the THV are
often difﬁcult to visualize in the standard parasternal
long-axis and apical TTE views, and it is necessary to
obtain off-axis/intermediary views to reveal these
jets.
To provide a more precise description of the
localization of the PVR jets, the face of a clock can be
applied to the short-axis view using the tricuspid
valve septal leaﬂet insertion as the 9 o’clock reference
(Figure 3). The most frequent locations of PVR
following TAVR are at the 1 to 2, 5 to 6, and 9 to 11
o’clock positions (19), which correspond to the com-
missures of the native aortic valve (Figure 5). Indeed,
at these locations, the stent, which has a circular
shape with limited ﬂexibility, does not conform to the
triangular conﬁguration of the commissure (20).
These PVR jets arising from the native commissures
often splay widely when they enter into the LVOT
(Figure 5). PVR may also occur at other locations
because of malapposition of the stent, which is often
related to bulky calciﬁcations. These jets tend to be
more restricted and splay less as they enter into the
LVOT.
The circumferential extent of the PVR jet(s) esti-
mated in the parasternal short-axis view is the main
FIGURE 6 Circumferential Extent of the PVR for Assessment of Regurgitation Severity
This ﬁgure shows TTE short-axis images with various degrees of regurgitant jet circumferential extent and PVR severity (yellow arrows show PVR jets): <5%, trace PVR
(A); 5% to 15%, mild PVR (B); 15% to 25%, mild-to-moderate PVR (C and D); 15% to 25% but larger jet width, moderate PVR (E); >30%, moderate-to-severe PVR (F).
(G and H) Show TTE parasternal long-axis (G) (Online Video 10) and short-axis (H) (Online Videos 11 and 12) views and schematic representations of an eccentric anterior
PVR jet. On the short-axis view (H), the circumferential extent of this eccentric jet may easily be overestimated (see Online Videos 11 vs. 12). There is also a small posterior
jet visible in the parasternal long- and short-axis views (Online Videos 10 and 11). The anterior jets are often eccentric because when they enter into the LVOT, they are
deviated posteriorly by the prominent septal bulge (see schematic representation in the left bottom panel). Abbreviations as in Figures 3 and 5.
Continued on the next page
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350parameter that has been proposed in the guidelines
for semiquantitative assessment of PVR severity
(Table 1, Figures 4 and 6, Online Videos 1, 11, and 12)
(11,14). This parameter is assessed by estimating
visually the approximate number of minutes occu-
pied by the PVR jet(s) according to the face of a clock
and by dividing this number by 60 min (Figures 5 and
6). The circumferential extent is then expressed as a
percentage and, according to the 2009 ASE guide-
lines (11), a value between 10% and 20% would
correspond to moderate PVR, and a value >20% to
severe PVR. However, these cutpoint values have
been revised in the 2012 Valve Academic Research
Consortium 2 recommendations (13) and an extent
between 10% and 30% corresponds to moderate
PVR, and >30% to severe PVR, to correspond tothe grading scheme used by the PARTNER-I trial
(1,2). However, the PVR circumferential extent
may vary substantially depending on the plane of
interrogation (Figure 5). It is thus important to
scan the entire height of the stent and use the short-
axis plane where the vena contracta of the jet is
the smallest. An image plane that is too high
(above the stent or upper portion of the stent) may
underestimate the regurgitation, whereas a plane
that is too low in the LVOT may overestimate the
regurgitation severity as a result of rapid broad-
ening of the jet downstream of the vena contracta
(Figure 5).
The circumferential extent of the jet becomes even
more complex and less reliable when multiple and/or
eccentric jets are present. In case of multiple-jet PVR,
FIGURE 6 Continued
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351the vena contracta may be at different levels
depending on the jets, and this may, therefore, require
several image planes to assess the overall circumfer-
ential extent of PVR. Moreover, the PVR jets, and
particularly the anterior jets may be very eccentric and
in such case, the jet may be directed across the short-
axis plane, which may lead to an overestimation of
the circumferential extent and thus of the severity of
PVR (Figures 6G and 6H, Online Videos 10, 11, and 12).
Inversely, the severity of PVR may be underestimated
when a jet does not occupy a large circumferential
extent but has a greater radial width (Figure 6E).
Recent studies revealed that this parameter correlates
poorly with the severity of PVR measured by CMR
(Figure 7) (21,22).
Hence, the grading of PVR should not rely solely on
the examination of the short-axis view and estima-
tion of circumferential extent. This measure should
be integrated with other views and parameters, as
described below.The width of the jet at its origin is probably the
most important parameter to consider for grading
the severity of PVR. It is assessed visually in the
parasternal and apical views, and an estimate of the
ratio of the jet width to the LVOT diameter may
be provided and expressed in percentage (Table 1). It
is important to visualize the origin of the jet(s) just
underneath the apical border of the stent before the
jet dispersion, which can be challenging (Figures 4
and 5). The PVR jets located posteriorly may be difﬁ-
cult to visualize and assess because they tend to
merge with the mitral ﬂow (Figure 4I, Online Video 9).
The vena contracta of the PVR jets is often difﬁcult
to visualize and measure by 2-dimensional color
Doppler echocardiography. Furthermore, as opposed
to native AR or central prosthetic AR, the vena con-
tracta of PVR is not circular and is often irregular
(Figure 5). 3D echocardiography may eventually
overcome the limitations of 2-dimensional and stan-
dard Doppler measurements for quantifying PVR.
FIGURE 7 Comparison of PVR Severity Assessed With the Jet Circumferential Extent by Doppler-Echocardiography vs. the Regurgitation Fraction by
CMR Imaging
(A) Shows the comparison of AR severity based on the PVR circumferential extent by Doppler echocardiography versus the regurgitant fraction (RF) by cardiac magnetic
resonance (CMR). (B and C) Show 2 examples where circumferential extent overestimated (B) and underestimated (C) the AR severity as assessed by CMR RF. Adapted
with permission from Ribeiro et al. (21). Abbreviations as in Figure 1.
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352Studies using 3D TTE have shown the feasibility of
measuring the 3D vena contracta of PVR following
TAVR (Figure 8, Table 1) (23,24).
PVR jet features. Besides the size and circumferential
extent of the jet at its origin, other characteristics
may be used to grade the severity of PVR, including
the number of jets and the visualization of the jet
path along the stent and/or of the proximal ﬂow
convergence (Figure 9, Table 1). The number of jets
visualized at echocardiography correlates with the
regurgitant fraction measured by CMR (21). Never-
theless, a single jet can be severe if it has a large
vena contracta. On the other hand, 3 mild jets may
correspond to moderate PVR or more. When the
path of the PVR jet is clearly visible along the
whole length of the stent, this is often associated
with moderate or greater PVR (Figure 9). The
proximal ﬂow convergence is rarely visible in the
case of PVR, but when it is, this is often a marker of
signiﬁcant PVR. As for native AR, the use of
regurgitant jet area and length are no longer rec-
ommended because these parameters are unreliable
indicators of AR severity, given their dependence
on blood pressure and aortic and ventricularcompliance. Very short jets are rarely greater than
mild, but longer jets can be mild to severe
depending on the size of their vena contracta
and other hemodynamic variables. Online Videos 13,
14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28,
29, 30, 31, 32, 33, 34, 35, and 36 provide color
Doppler images of representative cases for each
class (except none and severe PVR) of the 5-class
grading scheme proposed in Table 1.
Doppler parameters. Doppler parameters, including
the signal intensity and pressure half-time of the
continuous-wave envelope of the regurgitant jet(s)
and the timing and velocity of the diastolic ﬂow
reversal in the descending aorta, may also be
determined to corroborate PVR severity (Figure 10,
Table 1). However, the accuracy of these parameters
is limited in the early post-procedural period be-
cause of the acute nature of PVR and the frequent
coexistence of moderate–severe diastolic dysfunc-
tion. Furthermore, pressure half-time is highly
heart-rate dependent.
The ﬂow reversal in the descending aorta and the
end-diastolic velocity measured by pulsed-wave
Doppler is strongly inﬂuenced by aorta compliance,
FIGURE 8 Usefulness of 3D Color Doppler to Assess PVR
In this case, the patient has a PVR jet along the posterolateral aspect of the THV stent that is imaged on simultaneous multiplane imaging (A).
However, the level of imaging is just above the lowest edge of the THV stent. On 3-dimensional (3D) color Doppler (B), the regurgitant jet does
not appear as signiﬁcant. Using multiplanar reconstruction (C), the vena contracta can be imaged and the effective regurgitant oriﬁce area
(EROA) measured (D). Abbreviations as in Figure 5.
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353and increased arterial stiffness may result in
false-positive results. Indeed, several studies re-
ported that holodiastolic and rapid ﬂow reversal can
occur in elderly patients with stiff aorta, even in the
absence of signiﬁcant AR (25). This considerably
limits the usefulness of aortic ﬂow reversal in the
TAVR population, given that these patients are
generally old and the majority have markedly
reduced arterial compliance.
Quantitative parameters. Quantitative methods such
as the Proximal Isovelocity Surface Area method are
rarely applicable to PVR (11). The regurgitant vol-
ume may, however, be estimated by calculating
the difference between the left and right ventricu-
lar (RV) stroke volumes, providing that there is
no signiﬁcant pulmonary regurgitation (Figure 10,Table 1). This parameter is, however, subject to
signiﬁcant interobserver and intraobserver mea-
surement variability, which is, in large part, related
to the difﬁculty of measuring the RV outﬂow tract
diameter by TTE (24). Newer methods based on
real-time 3D velocity color ﬂow Doppler echocardi-
ography allow automated quantiﬁcation of the ve-
locity, ﬂow rate, and ﬂow volume in any given
region of the heart from color Doppler images (26).
This method provides excellent feasibility, accuracy,
and reproducibility for the quantitation of mitral
inﬂow and aortic stroke volumes. The application of
this method to the measurement of LV and RV
stroke volumes would potentially permit one to
obtain a more accurate measure of the PVR regur-
gitant volume.
FIGURE 9 PVR Jet Features Associated With Regurgitation Severity
This ﬁgure shows some of the PVR jet features often associated with moderate or greater PVR: large width of the jet at its origin (white arrow),
visible path of the PVR jet along the stent (black arrows), visible proximal ﬂow convergence (yellow arrows) (A and B); abnormal THV stent
shape with mal-apposition (yellow arrow) and large vena contracta of the PVR jet (white arrow) in the short-axis views (C and D); multiple jets
with large width at the origin in multiple views (white arrows) (E and F). Online Videos 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28,
29, 30, 31, 32, 33, 34, 35, and 36 present representative color Doppler images of the different classes of PVR severity. Abbreviations as in
Figure 5.
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FIGURE 10 Doppler Parameters for the Assessment of PVR
(A) The pressure half-time (PHT) measured on the continuous-wave Doppler aortic regurgitant signal may be used to corroborate the AR
severity: in the example shown, the PHT is short (242 ms), consistent with severe AR. (B) The ﬂow reversal and end-diastolic velocity obtained
by pulsed-wave Doppler in the descending aorta may be used to differentiate moderate from severe AR: in the example shown, there is
holodiastolic ﬂow reversal with high end-diastolic velocity (22.5 cm/s), consistent with severe AR. However, in the elderly patients with
noncompliant aorta and/or left ventricular (LV) diastolic dysfunction, there are often false-positive cases with both pressure half time and
aortic ﬂow reversal. (C, D, E, F) A quantitative assessment of the aortic regurgitant volume may be obtained by calculating the difference of the
stroke volume measured in the LV outﬂow tract (C and D) minus the stroke volume measured in the right ventricular outﬂow tract (RVOT) (E
and F). To measure RVOT diameter, it is recommended to use both the RV outﬂow view and the short-axis view (E). Color Doppler may be
useful to better delineate the borders of the RVOT. Abbreviations as in Figure 1.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 3 , 2 0 1 5 Pibarot et al.
M A R C H 2 0 1 5 : 3 4 0 – 6 0 Assessment of Paravalvular Regurgitation
355CMR IMAGING. There are a number of advantages of
CMR for assessing PVR post-TAVR including the
ability to measure regurgitant volumes irrespective of
regurgitant jet number or morphology (24), highreproducibility of measurements (27), and the ability
to measure regurgitant volume for multiple valve
types (5,17,28). The consequences of PVR on LV vol-
umes and function can also be assessed using
FIGURE 11 Assessment of PVR Severity by CMR
(A and B) This is an example of CMR images obtained with steady-state free precession acquisition (blue lines ¼ planning lines for imaging planes of velocity-encoded
CMR) in a patient with PVR. (C and D) Magnitude image (C) and phase velocity map (D). (E) Time-velocity curve of aortic ﬂow rate, the red area between the curve and
the x-axis represents regurgitant ﬂow. Adapted with permission from the BMJ Publishing Group, Ltd., from Orwat et al. (22). Abbreviations as in Figures 1 and 7.
Pibarot et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 3 , 2 0 1 5
Assessment of Paravalvular Regurgitation M A R C H 2 0 1 5 : 3 4 0 – 6 0
356standard cine CMR sequences. Unfortunately, the
pitfalls of the technique discussed below, as well as
cost and access to scanners, continues to be major
barriers to widespread use.
Phase-contrast velocity mapping has become the
primary mode for assessing regurgitant volume by
CMR. For this purpose, phase-contrast imaging is
obtained in a short-axis plane cutting the aorta just
above the THV stent to measure the antegrade and
retrograde aortic ﬂows and then to calculate the
regurgitant volume and fraction (Figure 11) (22).
Although CMR consistently shows low variability
of measurements, numerous pitfalls also exist (27).
Studies are typically gated, and arrhythmias may
reduce the accuracy of measurement. Patient
discomfort and movements may cause motionartifacts and reduce the quality of the image acqui-
sition. The accuracy of CMR to grade PVR may also
be altered by ﬂow turbulences and loss of signal in the
vicinity of the THV stent. Finally, because the coro-
nary artery diastolic ﬂow is included in the
ﬁnal regurgitant volume assessment, CMR may
lead to a slight overestimation of AR and does not
allow precise separation between mild, trace, and
no AR.
Recent studies reported that the incidence
of moderate/severe PVR as evaluated by CMR is 2- to
3-fold higher compared with TTE. These discrep-
ancies might be, in part, related to an underestima-
tion of PVR by TTE as a result of the fact that PVR jets
are often multiple, eccentric, irregular, conﬁned
against the LVOT wall, and potentially masked by the
FIGURE 12 Algorithm for the Intraprocedural Management of PVR
No
Yes
MildTrace Mild-to-Moderate Moderate Severe
ReassessNo More Procedures
RA fo eergeD ynARA oN
Cineangiography/TEE/TTE after THV Deployment
TEE / TTE for quantitation of AR severity and identification
of AR location (paravalvular vs. central) and etiology 
Corrective Procedures
  Balloon  post-dilation
  Valve-in-valve
  Closure of the leak with a plug
Presence of vulnerability factors to AR†
     and/or
Absence of high risk features/ low likelihood
of success with corrective procedures‡
Moderate-
to-Severe
†No pre-procedural AR, severe LV concentric hypertrophy with small LV cavity, and moderate-to-severe diastolic dysfunction. ‡High-risk features: bulky
calciﬁc nodules within the sinuses of Valsalva or annulus which threaten the integrity of the aortic root/annulus, or left main coronary artery; low likelihood
of success: severely malpositioned valves, or bulky calcium adjacent to the lower skirt that prevent apposition of the stent frame with native tissue.
Abbreviations as in Figures 1, 2, 3, and 10.
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357acoustic shadowing (9,11). On the other hand, the
inherent pitfalls of CMR may also lead to an over-
estimation of PVR with this technique. Furthermore
and importantly, the cutoff values of CMR regurgi-
tation volume and fraction used to grade AR severity
(Table 1) are not well validated and vary substantially
from one study to another. Gelfand et al. (29)
reported that the CMR regurgitant fractions that
optimized the correlation with echocardiographic
grades (using an integrative approach) of mild,
moderate, moderate–severe, and severe, were: #15%,
16% to 25%, 26% to 48%, and >48%, respectively
(Table 1). Gabriel et al. (30), however, reported sig-
niﬁcantly lower CMR regurgitant fraction cutpoints
for the same echocardiographic grades: Grade 0 to
1, <8%; Grade 2, 8% to 19%; Grade 3, 20 to 29%;
and Grade 4, 30%. The studies that have compared
the severity of PVR by echocardiography versus CMR
(9,11) used the lower cutpoint values proposed by
Gabriel et al. (30), and this may have contributed tothe discrepancies observed between these 2
modalities.
Hence, CMR may help to corroborate the severity
of regurgitation in cases where echocardiography re-
mains inconclusive and/or when there is discordance
between the echocardiographic grading of PVR
severity and patient’s symptomatic status and/or
degree of LV dilation/dysfunction. However, further
outcome studies are urgently needed to validate the
cut-point values of CMR regurgitant volume and
fraction that should be used to grade the severity of
AR, including PVR. Until such studies are conducted,
caution is warranted using CMR regurgitant volumes
and/or fractions in isolation.
MANAGEMENT OF PVR
Despite the improvements in THV design, sizing, and
positioning, a substantial proportion of the patients
undergoing TAVR still present with signiﬁcant PVR
FIGURE 13 Balloon Post-Dilation to Correct PVR
(A) TEE long-axis view of valve prosthesis implantation; the white arrow indicates balloon inﬂation. (B and C) TEE long- and short-axis images immediately after THV
deployment; white arrows indicate moderate PVR. (D) TEE long-axis image of balloon post-dilation with a slightly larger balloon; white arrows indicate balloon inﬂation.
(E and F) TEE long- and short-axis images immediately after balloon post-dilation showing a marked reduction in PVR (white arrows). Reproduced with permission from
Nombela-Franco et al. (31). Abbreviations as in Figures 1 and 2.
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358following deployment of the THV, and corrective in-
terventions, including post-dilation, valve-in-valve,
or leak closure, may be considered during or after the
procedure.
INTRAPROCEDURAL MANAGEMENT OF PVR. Accu-
rate assessment of the presence and severity of
PVR immediately after THV implantation is key
for optimal utilization of additional procedures
(Figure 12). In the presence of moderate or greater
PVR or of mild-to-moderate PVR in some speciﬁc
situations (Figure 12), balloon post-dilation should be
considered to reduce PVR (Figure 13). This procedure
is currently performed in about 10% to 20% of pa-
tients following TAVR, and it reduces the severity of
PVR by at least 1 grade in more than two-thirds of the
patients, with the achievement of mild or less than
mild AR in about one-half of them (31). However,
balloon post-dilation may be associated with
increased risk of cerebrovascular events and annular
trauma, as well as with increased incidence of centralregurgitation (31,32). Hence, a rational utilization of
this procedure is recommended (Figure 12). A valve-
in-valve procedure (i.e., implantation of a second
THV within the ﬁrst one) is generally used to correct
central regurgitation. However, this procedure may
also be considered for PVR when the balloon post-
dilation fails to reduce a moderate/severe PVR that
is likely caused by inadequate positioning of the THV
(i.e., too low or too high implantation depth)
(Figure 14).
POST-PROCEDURAL MANAGEMENT OF PVR. Pa-
tients with PVR should receive a close clinical and
echocardiographic follow-up. If there is uncertainty
regarding the grading of PVR at TTE and/or TEE, CMR
may be used to corroborate PVR severity (21,22). Pa-
tients with PVR should have aggressive control of
systemic arterial hypertension because it may worsen
the regurgitant volume leading to a negative impact
on LV geometry and function.
FIGURE 14 Valve-in-Valve Procedure to Correct PVR
TEE image showing an undersized SAPIEN 26 mm (Edwards Lifesciences, Irvine, California) (A); deep gastric color Doppler image with severe PVR (yellow arrows) (B); 3D
color Doppler image showing severe PVR (C); CoreValve (Medtronic, Minneapolis, Minnesota) implanted in the SAPIEN valve with post-dilation to maximally expand,
particularly the lower skirt (see low position of the balloon) (D); 2D and 3D color Doppler images showing mild PVR (yellow arrows) (E and F). Abbreviations as in
Figures 2 and 8.
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359Transcatheter closure of paravalvular leaks may
be performed during the TAVR procedure if balloon
post-dilation and/or valve-in-valve fail to correct a
moderate/severe PVR or it can be done after TAVR if
symptoms persist/recur or if LV dilation/dysfunction
occurs (33).
CONCLUSIONS
PVR is frequent following TAVR and has a negative
impact on outcomes. Because PVR jets are often
multiple, irregular, and eccentric, the imaging and
grading of PVR by echocardiography is challenging.
Hence, a multiwindow, multiparametric, integra-
tive approach is essential to accurately assess the
severity of PVR. Variations of PVR grading scales
have added to the confusion. A proposed unifying
and clarifying grading scale may help to ultimately
improve the accuracy of the echocardiographic
grading of PVR severity. The proposed 5-class
scheme will have to be validated with outcome
data. Newer approaches based on 3D color Dopplermethods should improve the feasibility, accuracy,
and reproducibility of PVR quantitation in the near
future. Other modalities such as cineangiography,
invasive hemodynamic, and CMR may also be useful
to complement or corroborate echocardiography for
the grading of PVR during and after the procedure
but should not be used in isolation. The use of
corrective procedures such as balloon post-dilation,
valve-in-valve, and/or leak closure may be consid-
ered depending on the severity of PVR and the
anticipated risk of complications associated with
these procedures.
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